June 16, 2020
Coala Life Partners With Proximo Medical to Commercialize Coala Heart Monitor in the United States
June 16, 2020—Proximo Medical, LLC, announced a partnership with Coala Life, a Swedish-headquartered digital health company, in select United States markets.
Proximo Medical provides business acceleration solutions for medical device commercialization of both startup and established medical device technologies looking to expand adoption in the United States.
The Coala heart monitor provides real-time, diagnostic-quality electrocardiogram (ECG) analysis and heart sound recordings simultaneously to patient and health care providers to detect and diagnose heart disease.
When connected to a smartphone through Bluetooth, the Coala monitor takes 1 minute to capture both ECG and heart sounds in the chest and thumb-ECG recording. Cloud-based algorithms analyze recordings in real-time and results are presented instantly to both patient and prescribing physician.
In April 2020, the Coala Life announced that the FDA Emergency Guidance allowed expanded indications for the device for use enabling physicians to remotely, in real-time, monitor patients’ hearts and lung sounds for COVID-19 respiratory diagnostic exams, as well as detecting nine of the most common arrythmias.
“Physicians need to meet patients where they are,” commented Jerome V. Dwyer, MD, in the announcement. Dr. Dwyer is a cardiologist in St. Louis, Missouri. “Cardiology has quickly shifted to telemedicine solutions and the Coala heart monitor offers a unique, customized diagnostic and treatment solution with data available to patient and physician in real-time.”